Volume 125, Issue 3 , Pages 617-625.e6, March 2010
Early-life chlamydial lung infection enhances allergic airways disease through age-dependent differences in immunopathology
Background
Asthma typically originates in early-life, and the impact of infection during immunologic maturation is a critical factor in disease pathogenesis. The progression of aberrant TH2 cell responses and disease development has been attributed to a lack of infections. However, exposure to specific pathogens such as Chlamydia may alter immunologic programming and predispose to asthma.
Objective
To investigate the effects of chlamydial infection at different ages on allergic airways disease in later life.
Methods
Neonatal, infant, or adult BALB/c mice were infected and 6 weeks later were sensitized and subsequently challenged with ovalbumin. Hallmark features of allergic airways disease were compared with uninfected allergic and nonallergic controls.
Results
Early-life (neonatal and infant) but not adult chlamydial infection enhanced the development of hallmark features of asthma in ovalbumin-induced allergic airways disease. Notably early-life infection increased mucus-secreting cell numbers, IL-13 expression, and airway hyperresponsiveness. Neonatal infection attenuated eosinophil influx and ovalbumin-specific TH2 cytokine release and numbers of activated myeloid dendritic cells (DCs) in lymph nodes. By contrast, infant infection augmented features of allergic inflammation with increased airway eosinophils, TH2 cytokine, and DC responses. Both neonatal and infant infection increased systemic DC-induced IL-13 release from CD4+ T cells. The timing of infection had significant effects on lung structure because neonatal but not infant or adult infection induced increases in alveolar diameter.
Conclusion
Early-life respiratory chlamydial infections modulate immune responses, alter lung function and structure, and enhance the severity of allergic airways disease in later life.
Key words: Asthma, Chlamydia, immunologic programming, lung structure, dendritic cell, IL-13, infant, neonate, lung function
Abbreviations used: AHR, Airway hyperresponsiveness, DC, Dendritic cell, mDC, Myeloid dendritic cell, MLN, Mediastinal lymph node, Treg, Regulatory T
Supported by grants from the National Health and Medical Research Foundation of Australia (project grants 401238 and 569219), the Asthma Foundation of NSW, the Rebecca Cooper Medical Research Foundation, the University of Newcastle project grants and Brawn Post-doctoral Fellowship, the Hunter Medical Research Institute, and the Australian Research Council (0559210).
Disclosure of potential conflict of interest: K. W. Beagley has received research support from NHMRC Australia and ARC Australia and is a councilor for the Society for Mucosal Immunology. The rest of the authors have declared that they have no conflict of interest.
PII: S0091-6749(09)01545-0
doi:10.1016/j.jaci.2009.10.018
© 2010 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
Volume 125, Issue 3 , Pages 617-625.e6, March 2010
